Orion Oyj
OMXH:ORNBV
Relative Value
The Relative Value of one ORNBV stock under the Base Case scenario is hidden EUR. Compared to the current market price of 68.2 EUR, Orion Oyj is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
ORNBV Competitors Multiples
Orion Oyj Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| FI |
O
|
Orion Oyj
OMXH:ORNBV
|
9.6B EUR | 5.9 | 30.8 | 24 | 24 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
976.4B USD | 15 | 47.3 | 31.9 | 33.9 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
590.4B USD | 6.3 | 22 | 15.3 | 18.8 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
294.6B CHF | 4.8 | 31.3 | 13.2 | 15.4 | |
| CH |
|
Novartis AG
SIX:NOVN
|
248.5B CHF | 5.7 | 22.9 | 14.1 | 18.2 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
236B GBP | 5.4 | 31.1 | 17.2 | 24.2 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
306.5B USD | 4.7 | 16.8 | 10.5 | 12.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.5 | 10.4 | 7.7 | 9.1 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.2B USD | 2.5 | 19.8 | 7.4 | 9.9 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
123.7B USD | 2.6 | 17.5 | 7.3 | 9 |